BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis

TSX:BLCO • CA0717051076

24.55 CAD
-0.03 (-0.12%)
Last: Feb 23, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, BLCO scores 4 out of 10 in our fundamental rating. BLCO was compared to 16 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • BLCO had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • BLCO's Return On Assets of -2.21% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
  • BLCO's Return On Equity of -4.74% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 0.70%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • BLCO had an Average Return On Invested Capital over the past 3 years of 1.45%. This is in line with the industry average of 0.70%.
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROIC 0.7%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • The Operating Margin of BLCO (2.33%) is better than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • With a decent Gross Margin value of 59.45%, BLCO is doing good in the industry, outperforming 68.75% of the companies in the same industry.
  • BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.33%
PM (TTM) N/A
GM 59.45%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
  • The number of shares outstanding for BLCO has been increased compared to 1 year ago.
  • Compared to 5 years ago, BLCO has more shares outstanding
  • The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • BLCO has an Altman-Z score of 0.90. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
  • BLCO has a better Altman-Z score (0.90) than 87.50% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
  • BLCO has a better Debt to Equity ratio (0.77) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACC0.07
WACC9.71%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO's Current ratio of 1.51 is amongst the best of the industry. BLCO outperforms 87.50% of its industry peers.
  • A Quick Ratio of 0.98 indicates that BLCO may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, BLCO belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.98
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

  • The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
  • BLCO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.23%.
  • The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%

3.2 Future

  • Based on estimates for the next years, BLCO will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.96% on average per year.
  • Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 5.49% on average per year.
EPS Next Y-10.8%
EPS Next 2Y13.94%
EPS Next 3Y20.44%
EPS Next 5Y19.96%
Revenue Next Year6.46%
Revenue Next 2Y6.14%
Revenue Next 3Y5.92%
Revenue Next 5Y5.49%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.61, the valuation of BLCO can be described as expensive.
  • Based on the Price/Earnings ratio, BLCO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • BLCO is valuated expensively when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • BLCO is valuated rather expensively with a Price/Forward Earnings ratio of 22.28.
  • BLCO's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLCO is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. BLCO is around the same levels.
Industry RankSector Rank
PE 41.61
Fwd PE 22.28
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLCO is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.21
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The decent profitability rating of BLCO may justify a higher PE ratio.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 20.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.94%
EPS Next 3Y20.44%

0

5. Dividend

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH + LOMB CORP

TSX:BLCO (2/23/2026, 7:00:00 PM)

24.55

-0.03 (-0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)02-18
Inst Owners11.05%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap8.70B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72.63
Price Target24.26 (-1.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.8%
PT rev (3m)12.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.77%
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 41.61
Fwd PE 22.28
P/S 1.28
P/FCF N/A
P/OCF 37.59
P/B 0.99
P/tB N/A
EV/EBITDA 20.21
EPS(TTM)0.59
EY2.4%
EPS(NY)1.1
Fwd EY4.49%
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)0.65
OCFY2.66%
SpS19.23
BVpS24.84
TBVpS-6.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.16
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROCE 0.97%
ROIC 0.7%
ROICexc 0.72%
ROICexgc 2.29%
OM 2.33%
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 9.05
Cap/Depr 85.28%
Cap/Sales 7.34%
Interest Coverage 250
Cash Conversion 31.07%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.98
Altman-Z 0.9
F-Score4
WACC9.71%
ROIC/WACC0.07
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-10.8%
EPS Next 2Y13.94%
EPS Next 3Y20.44%
EPS Next 5Y19.96%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.46%
Revenue Next 2Y6.14%
Revenue Next 3Y5.92%
Revenue Next 5Y5.49%
EBIT growth 1Y-38.95%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.23%
EBIT Next 3Y23.51%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%

BAUSCH + LOMB CORP / BLCO.CA FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.


What is the valuation status of BAUSCH + LOMB CORP (BLCO.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO.CA) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.